81 FR 54094 - NIOSH Center for Motor Vehicle Safety: Midcourse Review of Strategic Plan
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 81, Issue 157 (August 15, 2016)
Centers for Disease Control and Prevention
Federal Register Volume 81, Issue 157 (August 15, 2016)
| Page Range | 54094-54096 | |
| FR Document | 2016-19350 |
[Federal Register Volume 81, Number 157 (Monday, August 15, 2016)] [Notices] [Pages 54094-54096] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-19350] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [CDC-2016-0067, Docket Number NIOSH 270-A] NIOSH Center for Motor Vehicle Safety: Midcourse Review of Strategic Plan AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of public web meeting and request for comment. ----------------------------------------------------------------------- SUMMARY: The National Institute for Occupational Safety and Health of the [[Page 54095]] Centers for Disease Control and Prevention announces a public web meeting and an opportunity to comment on future directions for the NIOSH Center for Motor Vehicle Safety. To view the notice and related materials, visit http://www.regulations.gov and enter CDC-2016-0067 in the search field and click ``Search.'' TABLE OF CONTENTSDates: Addresses: For Further Information Contact: Supplementary Information: I. Background II. Public Web Meeting Instructions: DATES: The public web meeting will be held on September 14, 2016 from 1:00 p.m. to 5:00 p.m. Eastern Time, or after the last public commenter in attendance has spoken, whichever occurs first. The public web meeting will be a web-based event available only by remote access. Written comments submitted to the docket must be received by October 14, 2016. ADDRESSES: You may submit written comments, identified by CDC-2016-0067 and Docket Number NIOSH 270-A, by either of the following methods: Federal eRulemaking Portal: http://www.regulations.gov Follow the instructions for submitting comments. Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998. FOR FURTHER INFORMATION CONTACT: Dr. Rosa L. Rodriguez, Division of Safety Research, 1095 Willowdale Road, MS 1808, Morgantown, West Virginia 26505-2888, (304) 285-6299 (not a toll free number), rer3@cdc.gov; or Dr. Stephanie G. Pratt, Division of Safety Research, 1095 Willowdale Road, MS 1808, Morgantown, West Virginia 26505-2888, (304) 285-5992 (not a toll free number), sgp2@cdc.gov. SUPPLEMENTARY INFORMATION: I. Background The National Institute for Occupational Safety and Health (NIOSH) is seeking input on the progress and future direction of its Center for Motor Vehicle Safety to ensure that the program is (1) addressing goals outlined in the NIOSH Center for Motor Vehicle Safety: Strategic Plan for Research and Prevention, 2014-2018 http://www.cdc.gov/niosh/docs/2014-122/pdfs/2014-122.pdf; (2) meeting stakeholder needs; and (3) working effectively toward its overarching purpose of preventing work- related crashes and injuries. Motor vehicle crashes are the leading cause of work-related injury deaths in the United States. Millions of workers drive or ride in a motor vehicle as part of their jobs. The risk affects workers in all industries and occupations, whether they drive heavy or light vehicles on the job. Between 2003 and 2014, 22,000 workers died in work-related motor vehicle crashes. In 2013 alone, motor vehicle crashes at work cost U.S. employers $25 billion--$65,000 per nonfatal injury and $671,000 per death. NIOSH is the only U.S. federal agency whose mission encompasses prevention of work-related motor vehicle crashes and resulting injuries for all worker populations. Since 2014, the NIOSH Center for Motor Vehicle Safety has followed a 5-year strategic plan for research and prevention to work toward meeting five strategic goals. To help us review midcourse progress, we request your comment on the Center's work and goals. NIOSH is especially interested in comments that address the following topics: Research Priorities 1. What research should NIOSH consider pursuing during the remaining period covered by the NIOSH Center for Motor Vehicle Safety: Strategic Plan for Research and Prevention, 2014-2018? 2. What research should NIOSH begin planning to initiate beyond 2018? 3. Are there additional external research partners NIOSH should work with? Communications and Outreach 4. What specific resources or tools are most urgently needed to move prevention of work-related crashes forward? 5. What audience(s) for workplace crash-prevention information should NIOSH prioritize in planning its communication strategy? 6. What are your organization's preferred digital communication channels for receiving workplace crash-prevention information (e.g., email, social media, eNewsletter, Web page)? Use of NIOSH Products 7. How have you or your organization used information from the NIOSH Center for Motor Vehicle Safety? Of particular interest is information on changes made in workplace motor vehicle safety programs based on research results and/or communication materials and the impact of those changes. For information about the NIOSH Center for Motor Vehicle Safety, visit www.cdc.gov/niosh/motorvehicle. For information about Center for Motor Vehicle Safety progress towards meeting strategic goals, see the following supporting documents in http://www.regulations.gov: NIOSH Center for Motor Vehicle Safety: Strategic Plan for Research and Prevention, 2014-2018; NIOSH Center for Motor Vehicle Safety: Progress Report 2016 http://www.cdc.gov/niosh/motorvehicle/pdfs/progressreport.pdf and NIOSH Center for Motor Vehicle Safety: Performance Measures http://www.cdc.gov/niosh/motorvehicle/pdfs/performancemeasures.pdf. II. Public Web Meeting NIOSH will hold a public web meeting on September 14, 2016 from 1:00 p.m. to 5:00 p.m. Eastern Time, to allow for comments on future directions for the NIOSH Center for Motor Vehicle Safety. Attendance to this public web meeting is first come, first served. Confirm your attendance to this web meeting by sending an email to rolsavsky@cdc.gov with the subject line ``Attendance: Public web meeting'' by September 1, 2016. An email confirming registration will be sent from NIOSH and will include details needed to participate. Requests to make presentations at the public web meeting should be emailed to rolsavsky@cdc.gov with the subject line ``Request to present: Public web meeting'' by September 1, 2016. All requests to present should contain the name, address, telephone number, and relevant organizational affiliation(s) of the presenter. Presenters will be assigned a 10-minute slot on the agenda. Presenters who wish to use slides must email an electronic file in Microsoft PowerPoint format to rolsavsky@cdc.gov with the subject line ``Presentation: Public web meeting'' by September 1, 2016. An email confirming the presentation request will be sent from NIOSH and will include details needed to present and an approximate start time for the presentation. Presenters are encouraged to be on-line at the start of the web meeting, since the web meeting could end early and presenter may miss their opportunity to present. For assistance with technical difficulties the day of the web meeting, email Sydney Webb at yht4@cdc.gov. If a presenter is not on-line when his/her presentation is scheduled to begin, the remaining presenters will be heard in order. After the last scheduled presenter is heard, those who missed their opportunity may be allowed to present, limited by time available. Attendees who wish to speak, but did not submit a request for the opportunity to make a presentation, may be given [[Page 54096]] this opportunity after the scheduled presenters are heard, at the discretion of the presiding officer and limited by time available. Instructions All information received in response to this notice must include the agency name and docket number [CDC-2016-0067 and NIOSH 270-A]. The public web meeting, including all presentations and slides, will be recorded, transcribed, and posted without change to http://www.regulations.gov, including any personal information provided as well as all relevant comments received. All information received in response to this notice will also be available for public examination and copying at the NIOSH Docket Office, 1150 Tusculum Avenue, Room 155, Cincinnati, Ohio 45226-1998. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2016-19350 Filed 8-12-16; 8:45 am] BILLING CODE 4163-19-P
![54094 Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices
new treatments for active TB and latent accurate and timely national data and to and special studies of Mycobacterium
TB infection; (3) supports coordinated monitor progress toward the elimination tuberculosis, in collaboration with other
and standardized data management for of tuberculosis in the U.S.; (2) conducts branches; (3) administers contracts to
branch research, and serves as the Data analyses of national TB surveillance provide M. tuberculosis genotyping,
and Coordinating Center for the TB data to monitor national trends in TB in maintains a national database of
Trials Consortium, collaborating as order to assist n program planning, genotypes, and conducts operational
needed with both internal and external evaluation, and policy development and research to evaluate genotyping and
partners; (4) provides clinical support to identify areas for further study to optimize use of state-of-the-art methods;
and oversight for the distribution of guide elimination efforts; (3) conducts (4) serves as primary CDC source for
investigational drugs for the treatment surveillance-related studies that reference laboratory services for M.
and prevention of TB by CIOs/Scientific evaluate current TB surveillance tuberculosis; (5) administers grants and
Resources/Drug Service; (5) assesses the systems and develops new surveillance cooperative agreements to strengthen
need for and conducts clinical and field methods and systems in order to better laboratory activities and advance testing
trials of more specific and rapid tests to monitor and accelerate TB elimination services; (6) provides consultation,
diagnose active TB and latent TB efforts; (4) provides technical technical assistance, and training to
infection and to identify drug-resistant surveillance expertise to state and local state and municipal public health
TB in collaboration with the Laboratory TB control programs, other federal laboratories; (7) develops, evaluates, or
Branch; (6) collaborates with and agencies, and other organizations improves conventional and molecular
provides consultation and technical involved in TB prevention and control; methods for the detection,
assistance to national and international (5) conducts epidemiologic research to characterization, and susceptibility
organizations on the design and conduct assess the characteristics of persons testing of M. tuberculosis; (8) conducts
of clinical trials and research needs; (7) with M. tuberculosis disease and studies to define the role of bacterial
conducts, participates in, and infection in the U.S.; (6) analyzes virulence factors and host factors in
collaborates with other DTBE units in research findings to develop improved disease processes and protection, and
research on clinical, epidemiologic, interventions for eliminating develops, evaluates, and improves
immunologic and genetic aspects of TB tuberculosis and better analytic tools for methods for the diagnosis and
prevention and control; (8) collaborates future studies; (7) provides technical prevention of TB; (9) develops
with external partners in epidemiologic expertise to state and experimental models of TB and
implementation of research; (9) local tuberculosis control programs; (8) conducts studies on therapy,
maintains expertise and addresses supports the TB Epidemiologic Studies pathogenesis, and prevention for TB;
special research needs relevant to drug Consortium in the conduct of studies of (10) prepares manuscripts for
pharmacokinetics, microbiology, drug programmatically relevant publication in scientific journals; (11)
resistant TB & special populations, epidemiologic, behavioral, economic, presents findings at national and
including children and persons living laboratory, and operational research international scientific meetings; (12)
with HIV; (10) provides consultation concerning the identification, diagnosis, supervises and trains fellows in
and training to local, state, national and prevention and control of TB disease temporary or multi-year educationally-
international organizations and to TB and latent infection; (9) conducts based programs in areas related to the
program field staff, on design and molecular epidemiologic analyses of TB mission of the branch; and (13) elevates
conducts of clinical trials, TB cases to identify, track, and guide awareness of laboratory issues to ACET
therapeutics and diagnostics, health interventions to stop TB outbreaks; (10) and other stakeholders.
care systems research needs, decision investigates outbreaks of tuberculosis; Sherri Berger,
and economic analyses, evaluation (11) provides consultation and technical Chief Operating Officer, Centers for Disease
techniques, qualitative research expertise on TB surveillance, Control and Prevention.
methods, and research on TB epidemiology and outbreaks to state and [FR Doc. 2016–19302 Filed 8–12–16; 8:45 am]
transmission; (11) has responsibility for local tuberculosis control programs; (12) BILLING CODE 4160–18–P
Divisional engagement in preparing for analyzes TB outbreak investigation
and participating in trials of new TB findings in order to improve the ability
vaccines and when appropriate, of tuberculosis control programs to DEPARTMENT OF HEALTH AND
collaborates with private and public detect future outbreaks and respond to HUMAN SERVICES
institutions in the area of vaccine them promptly and appropriately to
development; (12) reports study results limit transmission; (13) supervises EIS Centers for Disease Control and
to public health practitioners through officers in the conduct of their two-year Prevention
direct communication, articles in assignments; (14) prepares manuscripts [CDC–2016–0067, Docket Number NIOSH
scientific journals and CDC for publication in scientific journals; 270–A]
publications, and oral and poster (15) presents findings at national and
presentations at national and international scientific meetings; and NIOSH Center for Motor Vehicle Safety:
international scientific and program (16) presents surveillance, Midcourse Review of Strategic Plan
meetings; (13) provides input into epidemiology, and outbreak findings to
AGENCY: National Institute for
statements and guidelines issued by the ACET and at national and international
Occupational Safety and Health
CDC, the ACET, and professional scientific meetings
(NIOSH) of the Centers for Disease
organizations; and (14) presents Laboratory Branch (CVJEJ). (1) Serves
sradovich on DSK3GMQ082PROD with NOTICES
Control and Prevention (CDC),
research issues and findings to ACET as the national reference laboratory in Department of Health and Human
and at national and international support of the mission of DTBE, Services (HHS).
scientific meetings. fulfilling public health function in ACTION: Notice of public web meeting
Surveillance, Epidemiology, and leadership, clinical and consultative and request for comment.
Outbreak Investigations Branch service, and research; (2) provides
(CVJEG). (1) Directs national laboratory support for epidemiological SUMMARY: The National Institute for
surveillance of tuberculosis to provide investigations, surveillance activities, Occupational Safety and Health of the
VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/81_FR_54251/page/1.svg)
![54096 Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices
this opportunity after the scheduled 2.0, ACF awarded grants to five tribal- The information collection activities
presenters are heard, at the discretion of affiliated organizations and 27 non- to be submitted in the request package
the presiding officer and limited by time tribal entities. The proposed data include: (1) Screening Interview to
available. collection activities described in this identify respondents for the HPOG 2.0
notice will provide data for the National Evaluation first-round
Instructions
implementation studies of the National telephone interviews. (2) HPOG 2.0
All information received in response and Tribal Evaluation of the 2nd National Evaluation first-round
to this notice must include the agency Generation of the Health Profession telephone interviews with management
name and docket number [CDC–2016– Opportunity Grants (i.e., the HPOG 2.0 and staff. These interviews will collect
0067 and NIOSH 270–A]. The public National Evaluation and the HPOG 2.0 information about the HPOG program
web meeting, including all Tribal Evaluation) as well as the impact context and about program
presentations and slides, will be study for the HPOG 2.0 National administration, activities and services,
recorded, transcribed, and posted Evaluation. OMB previously approved partner and stakeholder roles and
without change to http:// baseline data collection and informed networks, and respondent perceptions
www.regulations.gov, including any consent forms for the HPOG 2.0 of the program’s strengths. (3) HPOG 2.0
personal information provided as well Evaluations under OMB Control National Evaluation in-person
as all relevant comments received. All Number 0970–0462. implementation interviews with HPOG
information received in response to this The design for the HPOG 2.0 National personnel will collect information from
notice will also be available for public Evaluation features an implementation six HPOG 2.0 programs with promising
examination and copying at the NIOSH study and a cost benefit study. The approaches to the topic areas of specific
Docket Office, 1150 Tusculum Avenue, National Evaluation will use an interest to ACF. (4) HPOG 2.0 National
Room 155, Cincinnati, Ohio 45226– experimental design to measure and Evaluation participant contact update
1998. analyze key participant outcomes and forms. (5) HPOG 2.0 Tribal Evaluation
John Howard, impacts including completion of grantee and partner administrative staff
Director, National Institute for Occupational education and training, receipt of interviews will collect information on
Safety and Health, Centers for Disease Control certificates and/or degrees, earnings, high-level program strategies,
and Prevention. and employment in a healthcare career. partnerships in place to implement the
[FR Doc. 2016–19350 Filed 8–12–16; 8:45 am] This information collection clearance Tribal HPOG 2.0 program, program
BILLING CODE 4163–19–P request pertains to the implementation development and lessons learned. (6)
study and impact study. Future HPOG 2.0 Tribal Evaluation program
information collection requests will be implementation staff interviews will
DEPARTMENT OF HEALTH AND submitted related to the implementation collect information from instructors,
HUMAN SERVICES study, cost-benefit study, and impact trainers, recruitment and orientation
study. The goal of the implementation staff, and providers of program or
Administration for Children and study is to describe and assess the supportive services on Tribal HPOG 2.0
Families implementation, systems change, program processes including
outcomes and other important recruitment, screening, orientation,
Proposed Information Collection information about the operations of the provision of supportive services, and
Activity; Comment Request 27 non-tribal HPOG grantees, which are program implementation. (7) HPOG 2.0
Title: National and Tribal Evaluation operating 38 distinct programs. To Tribal Evaluation employer interviews
of the 2nd Generation of the Health achieve these goals, it is necessary to will collect information from local or
Profession Opportunity Grants. collect data about the non-tribal HPOG regional employers that are partnering
OMB NO.: 0970–0462 program designs and implementation, with Tribal HPOG 2.0 programs or have
Description: The Administration for HPOG partner and program networks, employed participants and collect
Children and Families (ACF), U.S. the composition and intensity of HPOG information on employers’ impressions
Department of Health and Human services received, participant of the tribal HPOG 2.0 program and
Services (HHS) is proposing data characteristics and HPOG experiences, program graduates. (8) HPOG 2.0 Tribal
collection activities as part of the Health and participant outputs and outcomes. Evaluation program participant focus
Profession Opportunity Grants (HPOG) The goal of the HPOG 2.0 Tribal groups will collect information on
Program. ACF has developed a multi- Evaluation is to conduct a participants’ perceptions, experience,
pronged research and evaluation comprehensive implementation and outcomes and satisfaction with the
approach for the HPOG program to outcome evaluation of the five Tribal Tribal HPOG 2.0 program. (9) HPOG 2.0
better understand and assess the HPOG 2.0 grantee programs. The Tribal Evaluation program participant
activities conducted and their results. evaluation will assess the HPOG 2.0 completer interviews will collect
Two rounds of HPOG grants have been programs administered by tribes, tribal information on the current employment
awarded—the first in 2010 (HPOG 1.0) organizations, and tribal colleges to status of the participants who
and the second in 2015 (HPOG 2.0). identify and assess how programmatic completed a training program and their
There are federal evaluations associated health profession training operations are perceptions of and satisfaction with the
with each round of grants. HPOG grants working; determine differences in Tribal HPOG 2.0 program. (10) HPOG
provide funding to government approaches being used when programs 2.0 Tribal Evaluation program
agencies, community-based are serving different sub-populations, participant non-completer interviews
sradovich on DSK3GMQ082PROD with NOTICES
organizations, post-secondary including participants with different will collect information on reasons
educational institutions, and tribal- characteristics and skill levels; and participants left the program, short-term
affiliated organizations to provide identify programs and practices that are outcomes, how they feel the program
education and training services to successful in supporting the target could be improved, and any plans for
Temporary Assistance for Needy population to achieve portable industry- future academic training.
Families (TANF) recipients and other recognized certificates or degrees as ACF will request approval for
low-income individuals. Under HPOG well as employment-related outcomes. additional information collection
VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1](https://thefederalregister.org/doc/81_FR_54251/page/3.svg)
Document Created: 2016-08-13 02:22:19
Document Modified: 2016-08-13 02:22:19
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of public web meeting and request for comment. | |
| Dates | The public web meeting will be held on September 14, 2016 from 1:00 p.m. to 5:00 p.m. Eastern Time, or after the last public commenter in attendance has spoken, whichever occurs first. The public web meeting will be a web-based event available only by remote access. Written comments submitted to the docket must be received by October 14, 2016. | |
| Contact | <bullet> Supplementary Information: | |
| FR Citation | 81 FR 54094 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR